Neogen Corporation (NEOG)
NASDAQ: NEOG · Real-Time Price · USD
9.87
+0.52 (5.56%)
At close: Jan 21, 2026, 4:00 PM EST
9.67
-0.20 (-2.03%)
After-hours: Jan 21, 2026, 7:08 PM EST
Neogen Revenue
Neogen had revenue of $224.69M in the quarter ending November 30, 2025, a decrease of -2.84%. This brings the company's revenue in the last twelve months to $880.32M, down -3.67% year-over-year. In the fiscal year ending May 31, 2025, Neogen had annual revenue of $894.66M, down -3.20%.
Revenue (ttm)
$880.32M
Revenue Growth
-3.67%
P/S Ratio
2.43
Revenue / Employee
$296,005
Employees
2,974
Market Cap
2.15B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2025 | 894.66M | -29.56M | -3.20% |
| May 31, 2024 | 924.22M | 101.78M | 12.37% |
| May 31, 2023 | 822.45M | 295.29M | 56.01% |
| May 31, 2022 | 527.16M | 58.70M | 12.53% |
| May 31, 2021 | 468.46M | 50.29M | 12.03% |
| May 31, 2020 | 418.17M | 3.98M | 0.96% |
| May 31, 2019 | 414.19M | 16.26M | 4.09% |
| May 31, 2018 | 397.93M | 39.65M | 11.07% |
| May 31, 2017 | 358.28M | 37.00M | 11.52% |
| May 31, 2016 | 321.28M | 38.20M | 13.50% |
| May 31, 2015 | 283.07M | 35.67M | 14.42% |
| May 31, 2014 | 247.41M | 39.88M | 19.22% |
| May 31, 2013 | 207.53M | 23.48M | 12.76% |
| May 31, 2012 | 184.05M | 11.36M | 6.58% |
| May 31, 2011 | 172.68M | 32.17M | 22.90% |
| May 31, 2010 | 140.51M | 21.79M | 18.35% |
| May 31, 2009 | 118.72M | 16.30M | 15.92% |
| May 31, 2008 | 102.42M | 16.28M | 18.90% |
| May 31, 2007 | 86.14M | 13.71M | 18.92% |
| May 31, 2006 | 72.43M | 9.68M | 15.42% |
| May 31, 2005 | 62.76M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NeoGenomics | 709.16M |
| OPKO Health | 642.07M |
| Veracyte | 495.14M |
| GeneDx Holdings | 402.19M |
| Twist Bioscience | 376.57M |
| CareDx | 358.00M |
| Castle Biosciences | 343.53M |
| Fulgent Genetics | 315.55M |
NEOG News
- 6 days ago - Neogen Corporation (NEOG) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 13 days ago - Neogen's Raised Outlook Fuels Turnaround Hopes, Stock Soars - Benzinga
- 13 days ago - Neogen Soars After Earnings Beat and Raised Outlook - Barrons
- 13 days ago - Neogen Corporation (NEOG) Q2 2026 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Neogen Announces Second-Quarter 2026 Results - Business Wire
- 14 days ago - Neogen Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts - Benzinga
- 16 days ago - Neogen® Announces Two Senior Leadership Appointments - Business Wire
- 4 weeks ago - Neogen Announces Second-Quarter Earnings Release Date - Business Wire